View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
 PRESS RELEASE

INVESTOR ALERT: Investigation of MabVax Therapeutics Announced by Holz...

ATLANTA--(BUSINESS WIRE)-- Holzer & Holzer, LLC is investigating whether MabVax Therapeutics Holdings, Inc. (“MabVax” or the “Company”) (NASDAQ: MBVX) complied with the federal securities laws. On January 30, 2018, MabVax announced that it received notice that the Securities and Exchange Commission (“SEC”) is investigating and examining certain of the Company’s filed registration statements and subsequent amendments. The price of MabVax stock fell significantly following the announcement. If you purchased MabVax common stock ...

 PRESS RELEASE

EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Cla...

NEW YORK--(BUSINESS WIRE)-- Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of purchasers of the securities of MabVax Therapeutics Holdings, Inc. (NASDAQ: MBVX) resulting from allegations that MabVax may have issued materially misleading business information to the investing public. On January 30, 2018, MabVax announced “that it received notice that the Securities and Exchange Commission (“SEC”) was conducting an investigation and examination pursuant to S...

Jonathan Moreland
  • Jonathan Moreland

Daily Insider Ratings Report: Jan 24, 2018

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch